These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7593729)

  • 1. Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three times daily dosage schedules.
    Gagiano CA; Müller FG; Berk M; Joubert PM; Brown RG; Schall R
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):4S-9S. PubMed ID: 7593729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three-times-daily dosage schedules.
    Gagiano CA; Hart GA; Bodemer W; Schall R
    Clin Neuropharmacol; 1994; 17 Suppl 1():S1-8. PubMed ID: 7954480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the efficacy and tolerability of moclobemide given as a single daily dose or in three divided doses per day for the treatment of patients with a major depressive episode (DSM-III-R).
    Newburn G; Edwards R; Thomas H; Collier J; Fox K; Collins C; Cramer D; Reeves J; Caracatsanis A
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):10S-15S. PubMed ID: 7593724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moclobemide in continuation treatment of major depressive episodes: an open follow-up study over six months.
    Gagiano CA; Müller FG; de Kock RF; Schall R
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):46S-50S. PubMed ID: 7593731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study.
    Kragh-Sørensen P; Müller B; Andersen JV; Buch D; Stage KB
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):24S-30S. PubMed ID: 7593726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moclobemide, imipramine and placebo in the treatment of major depression.
    Versiani M; Nardi AE; Mundim FD; Alves A; Schmid-Burgk W
    Acta Psychiatr Scand Suppl; 1990; 360():57-8. PubMed ID: 2248073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter double-blind study of moclobemide and maprotiline.
    Vaz-Serra A; Figueira ML; Firmino H; Albuquerque AJ; Jara JM; Pestana LC
    Clin Neuropharmacol; 1994; 17 Suppl 1():S38-49. PubMed ID: 7954483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of moclobemide and thioridazine versus moclobemide and placebo in the treatment of refractory, severe depression.
    Stabl M; Kasas A; Blajev B; Bajetta G; Zöchling R; Holsboer-Trachsler E; Realini R; Schäublin-Loidl M
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):41S-45S. PubMed ID: 7593730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moclobemide versus fluoxetine for major depressive episodes.
    Geerts S; Bruynooghe F; De Cuyper H; Demeulemeester F; Haazen L
    Clin Neuropharmacol; 1994; 17 Suppl 1():S50-7. PubMed ID: 7954484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of moclobemide compared with fluvoxamine in depressive disorder (DSM III). A French/Swiss double-blind trial.
    Bougerol T; Uchida C; Gachoud JP; Köhler M; Mikkelsen H
    Psychopharmacology (Berl); 1992; 106 Suppl():S102-8. PubMed ID: 1546121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners.
    Gachoud JP; Dick P; Köhler M
    Clin Neuropharmacol; 1994; 17 Suppl 1():S29-37. PubMed ID: 7954482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
    Duarte A; Mikkelsen H; Delini-Stula A
    J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moclobemide versus fluoxetine in the treatment of inpatients with major depression.
    Gattaz WF; Vogel P; Kick H; Kohnen R
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):35S-40S. PubMed ID: 7593728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
    Ucha Udabe R; Márquez CA; Traballi CA; Portes N
    Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moclobemide versus tranylcypromine in the treatment of depression.
    Rossel L; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():61-2. PubMed ID: 2248075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moclobemide and placebo in mild major depression: a double-blind randomized trial.
    Ose E; Holm P
    Psychopharmacology (Berl); 1992; 106 Suppl():S114-5. PubMed ID: 1546122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial.
    Roth M; Mountjoy CQ; Amrein R
    Br J Psychiatry; 1996 Feb; 168(2):149-57. PubMed ID: 8837903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. UK Moclobemide Study Group.
    Int Clin Psychopharmacol; 1994; 9(2):109-13. PubMed ID: 8056992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moclobemide versus fluoxetine for a major depressive episode.
    Reynaert C; Parent M; Mirel J; Janne P; Haazen L
    Psychopharmacology (Berl); 1995 Mar; 118(2):183-7. PubMed ID: 7617806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moclobemide compared with second-generation antidepressants in elderly people.
    De Vanna M; Kummer J; Agnoli A; Gentili P; Lorizio A; Anand R
    Acta Psychiatr Scand Suppl; 1990; 360():64-6. PubMed ID: 2248077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.